// App-Quantinova.ai

[AB0927] : LONG-TERM TNF? ANTAGONISTS TREATMENT EFFICACY IN AUTOIMMUNE UVEITIS

Researchers

Presenter

  • J. De La Iglesia Salgado

Principal Investigators

  • M. Ruiz Tudela

  • A. Garcia Muro

  • R. Menor Almagro

  • M. Ruiz Benitez

  • A. Rodriguez Suarez

  • J. Perez Venegas

Medical Centers

  • Rheumatology, Hospital de Jerez de la Frontera, Jerez de la Frontera, Spain

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Ophthalmology (OP)

Disease

  • Rheumatoid arthritis

  • Ankylosing spondylitis

  • Psoriatic arthritis

  • Autoimmune uveitis

  • Behcet disease

  • Sarcoidosis

  • Inflammatory Arthritis

  • Cataract

  • Glaucoma

  • Uveitis

Biomarkers

  • TNF Receptor Superfamily Member 1B

  • Tumor necrosis factor

Drug/Treatment

  • Hydroxychloroquine

  • Oraprine

  • Cyclosporine eent

  • Salazopyrin

  • Adalimumab

  • Infliximab

  • Etanercept

  • CHS-0214

  • Abatacept

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved